Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?

被引：14

作者：

Buti, Sebastiano ^{[1
]}

Bersanelli, Melissa ^{[1
]}

机构：

[1] Univ Hosp Parma, Parma, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 16期

关键词：

TRIAL; THERAPY;

D O I：

10.1200/JCO.2016.71.6506

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1858 / +

页数：2

共 5 条

[1] Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma [J].

Choueiri, T. K. ;

Escudier, B. ;

Powles, T. ;

Mainwaring, P. N. ;

Rini, B. I. ;

Donskov, F. ;

Hammers, H. ;

Hutson, T. E. ;

Lee, J-L ;

Peltola, K. ;

Roth, B. J. ;

Bjarnason, G. A. ;

Geczi, L. ;

Keam, B. ;

Maroto, P. ;

Heng, D. Y. C. ;

Schmidinger, M. ;

Kantoff, P. W. ;

Borgman-Hagey, A. ;

Hessel, C. ;

Scheffold, C. ;

Schwab, G. M. ;

Tannir, N. M. ;

Motzer, R. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) :1814-1823

[2] Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial [J].

Choueiri, Toni K. ;

Halabi, Susan ;

Sanford, Ben L. ;

Hahn, Olwen ;

Michaelson, M. Dror ;

Walsh, Meghara K. ;

Feldman, Darren R. ;

Olencki, Thomas ;

Picus, Joel ;

Small, Eric J. ;

Dakhil, Shaker ;

George, Daniel J. ;

Morris, Michael J. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06) :591-+

[3] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma [J].

Gore, M. E. ;

Szczylik, C. ;

Porta, C. ;

Bracarda, S. ;

Bjarnason, G. A. ;

Oudard, S. ;

Lee, S-H ;

Haanen, J. ;

Castellano, D. ;

Vrdoljak, E. ;

Schoeffski, P. ;

Mainwaring, P. ;

Hawkins, R. E. ;

Crino, L. ;

Kim, T. M. ;

Carteni, G. ;

Eberhardt, W. E. E. ;

Zhang, K. ;

Fly, K. ;

Matczak, E. ;

Lechuga, M. J. ;

Hariharan, S. ;

Bukowski, R. .

BRITISH JOURNAL OF CANCER, 2015, 113 (01) :12-19

[4] First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC [J].

Ko, J. J. ;

Choueiri, T. K. ;

Rini, B. I. ;

Lee, J-L ;

Kroeger, N. ;

Srinivas, S. ;

Harshman, L. C. ;

Knox, J. J. ;

Bjarnason, G. A. ;

MacKenzie, M. J. ;

Wood, L. ;

Vaishampayan, U. N. ;

Agarwal, N. ;

Pal, S. K. ;

Tan, M-H ;

Rha, S. Y. ;

Yuasa, T. ;

Donskov, F. ;

Bamias, A. ;

Heng, D. Y. C. .

BRITISH JOURNAL OF CANCER, 2014, 110 (08) :1917-1922

[5] Flare-up: An often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors [J].

Wolter, Pascal ;

Beuselinck, Benoit ;

Pans, Steven ;

Schoeffski, Patrick .

ACTA ONCOLOGICA, 2009, 48 (04) :621-624

← 1 →